Polymorphisms in the Janus kinase 2 (JAK)/ signal transducer and activator of transcription (STAT) genes: Putative association of the STAT gene region with familial breast cancer

Endocrine-Related Cancer

Volumn 14, Issue 2, 2007, Pages 267-277

  Vaclavicek, Annika ^a   Bermejo, Justo Lorenzo ^a   Schmutzler, Rita K ^b   Sutter, Christian ^c   Wappenschmidt, Barbara ^b   Meindl, Alfons ^d   Kiechle, Marion ^d   Arnold, Norbert ^e   Weber, Bernhard H F ^f   Niederacher, Dieter ^g   Burwinkel, Barbara ^a   Bartram, Claus R ^c   Hemminki, Kari ^a,h   Försti, Asta ^a,h  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIVERSITY OF REGENSBURG   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; STAT PROTEIN; STAT3 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; FAMILIAL DISEASE; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HAPLOTYPES; HETEROZYGOTE; HUMANS; JANUS KINASE 2; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STAT TRANSCRIPTION FACTORS;

EID: 34547735001     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-06-0077     Document Type: Article

References (30)

1. Akaike H 1973 Information theory and an extension of the maximum likelihood principle. Second International Symposium on Information Theory Budapest Akademiai Kiado pp 267-281.
2. Antoniou AC & Easton DF 2003 Polygenic inheritance of breast cancer: implications for design of association studies. Genetic Epidemiology 25 190-202.
3. Antoniou AC & Easton DF 2006 Models of genetic susceptibility to breast cancer. Oncogene 25 5898-5905.
4. Barrett JC, Fry B, Maller J & Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263-265.
5. Bromberg J & Darnell JE Jr 2000 The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19 2468-2473.
6. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N & Russo A 2003 STAT proteins: from normal control of cellular events to tumorigenesis. Journal of Cellular Physiology 197 157-168.
7. Clevenger CV 2004 Roles and regulation of stat family transcription factors in human breast cancer. American Journal of Pathology 165 1449-1460.
8. Clevenger CV, Furth PA, Hankinson SE & Schuler LA 2003 The role of prolactin in mammary carcinoma. Endocrine Reviews 24 1-27.
9. Coletta RD, Jedlicka P, Gutierrez-Hartmann A & Ford HL 2004 Transcriptional control of the cell cycle in mammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 9 39-53.
10. Cotarla I, Ren S, Zhang Y, Gehan E, Singh B & Furth PA 2004 Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. International Journal of Cancer 108 665-671.
11. Dupont WD & Plummer WD Jr 1998 Power and sample size calculations for studies involving linear regression. Controlled Clinical Trials 19 589-601.
12. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M et al. 2002 The structure of haplotype blocks in the human genome. Science 296 2225-2229.
13. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S et al. 2001 Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20 2499-2513.
14. Houlston RS & Peto J 2003 The future of association studies of common cancers. Human Genetics 112 434-435.
15. Levy DE & Darnell JE Jr 2002 Stats: transcriptional control and biological impact. Nature Reviews. Molecular Cell Biology 3 651-662.
16. Maguire P, Holmberg K, Kost-Alimova M, Imreh S, Skoog L & Lindblom A 2005 CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12. International Journal of Molecular Medicine 16 135-141.
17. De Marchis L, Cropp C, Sheng ZM, Bargo S & Callahan R 2004 Candidate target genes for loss of heterozygosity on human chromosome 17q21. British Journal of Cancer 90 2384-2389.
18. Meindl A 2002 Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. International Journal of Cancer 97 472-480.
19. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 66-71.
20. Osborne RJ & Hamshere MG 2000 A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Research 60 3706-3712.
21. Paez JG, Lin M, Beroukhim R, Lee JC, Zhao X, Richter DJ, Gabriel S, Herman P, Sasaki H, Altshuler D et al. 2004 Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Research 32 e71.
22. Philp JA, Burdon TG & Watson CJ 1996 Differential activation of STATs 3 and 5 during mammary gland development. FEBS Letters 396 77-80.
23. Revillion F, Bonneterre J & Peyrat JP 1998 ERBB2 oncogene in human breast cancer and its clinical significance. European Journal of Cancer 34 791-808.
24. Shan L, Yu M, Clark BD & Snyderwine EG 2004 Possible role of Stat5a in rat mammary gland carcinogenesis. Breast Cancer Research and Treatment 88 263-272.
25. Vaclavicek A, Hemminki K, Bartram CR, Wagner K, Wappenschmidt B, Meindl A, Schmutzler RK, Klaes R, Untch M, Burwinkel B et al. 2006 Association of prolactin and its receptor gene regions with familial breast cancer. Journal of Clinical Endocrinology and Metabolism 91 1513-1519.
26. Verma A, Kambhampati S, Parmar S & Platanias LC 2003 Jak family of kinases in cancer. Cancer and Metastasis Reviews 22 423-434.
27. Watson CJ 2001 Stat transcription factors in mammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 6 115-127.
28. Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK & Lau CC 2004 Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Research 32 e69.
29. Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, Levy DE & Stark GR 2005 Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Research 65 939-947.
30. Yu H & Jove R 2004 The STATs of cancer-new molecular targets come of age. Nature Reviews. Cancer 4 97-105.